Qiastat-Dx is a compact, fully integrated molecular diagnostic system from Qiagen. It enables fast and accurate testing for various infectious diseases, including respiratory infections and more. The system can process up to four samples simultaneously, providing results in one hour, making it ideal for point-of-care testing.
Qiastat-Dx is a portable, fully integrated molecular diagnostic system from Qiagen, designed to provide fast, reliable, and accurate results for various diagnostic tests. With a compact design and battery-powered operation, Qiastat-Dx is ideal for clinical and point-of-care settings, where a rapid diagnosis can be critical for patient management.
Using a combination of microfluidics, sample preparation, and PCR technology, Qiastat-Dx enables easy and rapid detection of nucleic acids from various biological samples. The system can perform multiple tests, from simple qualitative detection to complex multiplexed assays, with results available in at least one hour.
Qiastat-Dx includes a user-friendly interface and automated protocols to reduce the potential for human error and ensure reliable results. The system also features built-in controls and internal calibration to ensure the accuracy and reproducibility of results.
Qiastat-Dx also features connectivity options for remote monitoring and data transfer, allowing for real-time analysis and tracking of diagnostic results.
The system has been validated for various infectious disease assays, including SARS-CoV-2, and influenza, making it a versatile and valuable tool for clinical laboratories and healthcare providers. Additionally, Qiastat-Dx has received regulatory approval in various countries, including the US FDA, CE-IVD in Europe, and TGA in Australia, ensuring compliance with international quality standards.
This compact system combines nucleic acid extraction, amplification, and detection into a single closed cartridge, eliminating the need for separate devices or trained technicians. The Qiastat-Dx system is designed to deliver results in about an hour, allowing for timely diagnosis and treatment of infectious diseases such as respiratory infections, and gastrointestinal infections.
The Qiastat-Dx system uses real-time PCR technology to detect the presence of target nucleic acids in patient samples, with a sensitivity and specificity comparable to laboratory-based PCR tests. The user-friendly system has an intuitive touchscreen interface and a step-by-step guide for sample preparation and test setup. The Qiastat-Dx system is also scalable, able to process up to 8 samples simultaneously.